Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa | MicrobiomeTrials← Back to trialsNCT07756346
Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2028-09
Enrollment target: 40 participants Locations- UMass Chan Medical School, Worcester, Massachusetts, United States
Other microbiome trials you might be interested in
Hidradenitis
This is a parallel, Phase 2b, 3-arm, double-blind, randomized, multicenter, multinational, placebo-controlled, dose-rang…
Multiple LocationsEst. completion Jun 16, 2028
VitiligoAtopic DermatitisAlopecia AreataHidradenitis Suppurativa (HS)
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatol…
New York, United StatesEst. completion Aug 3, 2041